• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Back to the spring of 2020: facts and hope of COVID-19 outbreak.

作者信息

Zhou Guangbiao, Chen Saijuan, Chen Zhu

机构信息

State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine (Shanghai), Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

出版信息

Front Med. 2020 Apr;14(2):113-116. doi: 10.1007/s11684-020-0758-9. Epub 2020 Mar 14.

DOI:10.1007/s11684-020-0758-9
PMID:32172487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7089213/
Abstract
摘要

相似文献

1
Back to the spring of 2020: facts and hope of COVID-19 outbreak.回到2020年春天：新冠疫情的事实与希望。
Front Med. 2020 Apr;14(2):113-116. doi: 10.1007/s11684-020-0758-9. Epub 2020 Mar 14.
2
Novel coronavirus pneumonia emergency in Zhuhai: impact and challenges.珠海新型冠状病毒肺炎疫情：影响与挑战
J Hosp Infect. 2020 Apr;104(4):452-453. doi: 10.1016/j.jhin.2020.02.005. Epub 2020 Feb 14.
3
COVID-19: Time for precision epidemiology.新型冠状病毒肺炎：精准流行病学时代来临。
Exp Biol Med (Maywood). 2020 Apr;245(8):677-679. doi: 10.1177/1535370220919349. Epub 2020 Apr 17.
4
Personal protective equipment during COVID-19 outbreak at the First Affiliated Hospital of Wenzhou Medical University, China.中国温州医科大学附属第一医院在新冠疫情期间的个人防护装备
Int J Gynecol Cancer. 2020 Jun;30(6):897. doi: 10.1136/ijgc-2020-001493. Epub 2020 May 23.
5
The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment.新型冠状病毒（SARS-CoV-2）爆发的前 75 天：最新进展、预防和治疗。
Int J Environ Res Public Health. 2020 Mar 30;17(7):2323. doi: 10.3390/ijerph17072323.
6
A combination of COVID-19 and dengue fever in Bangladesh: Preparedness of Bangladesh.孟加拉国新冠病毒病与登革热合并感染情况：孟加拉国的应对准备
J Glob Health. 2020 Dec;10(2):020314. doi: 10.7189/jogh.10.020314.
7
In the fight against the new coronavirus outbreak, we must also struggle with human bias.在抗击新型冠状病毒疫情的过程中，我们还必须与人类偏见作斗争。
Nat Med. 2020 Mar;26(3):305. doi: 10.1038/s41591-020-0802-y.
8
China's successful control of COVID-19.中国对新冠疫情的成功防控。
Lancet Infect Dis. 2020 Nov;20(11):1240-1241. doi: 10.1016/S1473-3099(20)30800-8. Epub 2020 Oct 8.
9
Successful containment of COVID-19: the WHO-Report on the COVID-19 outbreak in China.成功遏制新冠病毒：世卫组织关于中国新冠疫情的报告。
Infection. 2020 Apr;48(2):151-153. doi: 10.1007/s15010-020-01409-4.
10
Neonatal Transport and COVID-19 outbreak.新生儿转运与新冠疫情
Air Med J. 2020 May-Jun;39(3):154-155. doi: 10.1016/j.amj.2020.03.003. Epub 2020 Mar 31.

引用本文的文献

1
The impact of temperature changes on the health vulnerability of migrant workers: an empirical study based on the China family panel studies.温度变化对农民工健康脆弱性的影响：基于中国家庭追踪调查的实证研究
Front Public Health. 2025 Feb 26;13:1519982. doi: 10.3389/fpubh.2025.1519982. eCollection 2025.
2
Trajectory of COVID-19 response and management strategy in China: scientific rationale driven strategy adjustments.中国 COVID-19 应对和管理策略的轨迹：基于科学依据的策略调整。
Front Med. 2024 Feb;18(1):19-30. doi: 10.1007/s11684-024-1074-6. Epub 2024 Apr 2.
3
Non-pharmaceutical interventions during COVID-19 in the UK and Spain: a rapid realist review.英国和西班牙在新冠疫情期间的非药物干预措施：一项快速现实主义综述。
Open Res Eur. 2022 Aug 26;2:52. doi: 10.12688/openreseurope.14566.2. eCollection 2022.
4
T cell immune response predicts survival in severely ill COVID-19 patients requiring venovenous extracorporeal membrane oxygenation support.T 细胞免疫反应可预测需要静脉-静脉体外膜肺氧合支持的重症 COVID-19 患者的生存情况。
Front Immunol. 2023 Aug 1;14:1179620. doi: 10.3389/fimmu.2023.1179620. eCollection 2023.
5
Outcomes of patients with coronavirus disease versus other lung infections requiring venovenous extracorporeal membrane oxygenation.冠状病毒病患者与其他需要静脉-静脉体外膜肺氧合的肺部感染患者的治疗结果。
Heliyon. 2023 Jun;9(6):e17441. doi: 10.1016/j.heliyon.2023.e17441. Epub 2023 Jun 17.
6
Emergency Protective Measures and Strategies of COVID-19: From Lifestyle to Traditional Chinese Medicine.新型冠状病毒肺炎的应急防护措施与策略：从生活方式到中医药
Clin Complement Med Pharmacol. 2023 Sep;3(3):100089. doi: 10.1016/j.ccmp.2023.100089. Epub 2023 Apr 6.
7
Molecular and Physiological Study in Patients with Coronavirus in Thi-Qar Province Iraq.伊拉克济加尔省冠状病毒患者的分子与生理研究。
Arch Razi Inst. 2022 Oct 31;77(5):2001-2006. doi: 10.22092/ARI.2022.358337.2199. eCollection 2022 Oct.
8
The Role of Neutrophil-to-Lymphocyte Ratio in Risk Stratification and Prognostication of COVID-19: A Systematic Review and Meta-Analysis.中性粒细胞与淋巴细胞比值在COVID-19风险分层和预后评估中的作用：一项系统评价和荟萃分析
Vaccines (Basel). 2022 Aug 1;10(8):1233. doi: 10.3390/vaccines10081233.
9
Leveraging artificial intelligence and data science techniques in harmonizing, sharing, accessing and analyzing SARS-COV-2/COVID-19 data in Rwanda (LAISDAR Project): study design and rationale.利用人工智能和数据科学技术协调、共享、访问和分析卢旺达 SARS-COV-2/COVID-19 数据（LAISDAR 项目）：研究设计和原理。
BMC Med Inform Decis Mak. 2022 Aug 12;22(1):214. doi: 10.1186/s12911-022-01965-9.
10
Management of Breast Cancer Patients During the Coronavirus Disease 2019 Pandemic: The Experience From the Epicenter of China, Wuhan.COVID-19 大流行期间乳腺癌患者的管理：来自中国疫情中心武汉的经验。
Clin Breast Cancer. 2022 Jan;22(1):e1-e7. doi: 10.1016/j.clbc.2021.04.014. Epub 2021 May 6.

本文引用的文献

1
Data-based analysis, modelling and forecasting of the COVID-19 outbreak.基于数据的 COVID-19 疫情分析、建模和预测。
PLoS One. 2020 Mar 31;15(3):e0230405. doi: 10.1371/journal.pone.0230405. eCollection 2020.
2
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.单细胞 RNA 测序数据分析受体 ACE2 的表达揭示了不同人体器官易感染 2019-nCoV 的潜在风险。
Front Med. 2020 Apr;14(2):185-192. doi: 10.1007/s11684-020-0754-0. Epub 2020 Mar 12.
3
Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19.西医结合中药治疗一家新冠病例。
Front Med. 2020 Apr;14(2):210-214. doi: 10.1007/s11684-020-0757-x. Epub 2020 Mar 13.
4
China's local governments are combating COVID-19 with unprecedented responses - from a Wenzhou governance perspective.中国地方政府正在以前所未有的举措应对新冠肺炎疫情——从温州治理角度来看。
Front Med. 2020 Apr;14(2):220-224. doi: 10.1007/s11684-020-0755-z. Epub 2020 Mar 12.
5
Therapeutic options for the 2019 novel coronavirus (2019-nCoV).2019新型冠状病毒（2019-nCoV）的治疗选择。
Nat Rev Drug Discov. 2020 Mar;19(3):149-150. doi: 10.1038/d41573-020-00016-0.
6
Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China.针对源自中国武汉的新型冠状病毒在疫情爆发情况下的治疗策略。
F1000Res. 2020 Jan 31;9:72. doi: 10.12688/f1000research.22211.2. eCollection 2020.
7
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.SARS-CoV-2 及其他 B 属β冠状病毒的细胞进入和受体使用功能评估。
Nat Microbiol. 2020 Apr;5(4):562-569. doi: 10.1038/s41564-020-0688-y. Epub 2020 Feb 24.
8
A distinct name is needed for the new coronavirus.新型冠状病毒需要一个独特的名称。
Lancet. 2020 Mar 21;395(10228):949. doi: 10.1016/S0140-6736(20)30419-0. Epub 2020 Feb 19.
9
Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19.支持中国抗击新冠肺炎疫情的科学家、公共卫生专业人员和医学专业人员的声明。
Lancet. 2020 Mar 7;395(10226):e42-e43. doi: 10.1016/S0140-6736(20)30418-9. Epub 2020 Feb 19.
10
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.